ArticleOpen veterinary journal2026
Albumin/Globulin ratio as a valuable marker for monitoring remdesivir therapy in feline infectious peritonitis.
Article in Open veterinary journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: R Feline infectious peritonitis (FIP) is a viral infection in cats that develops when a coronavirus mutates and causes an immune reaction throughout. The disease is usually fatal and requires extreme care to save the animal. Aim: This study examined the albumin-to-globulin (A/G) ratio as an important marker for monitoring the therapy effect. Simultaneously, the hematological and biochemical profiles of cats suffering from FIP were explored following intravenous treatment with remdesivir. Methods: Intravenous remdesivir was administered to 45 confirmed cases of FIP pets for 60 days. The cats were aged 3 months to 2 years because this is the most susceptible age in feline animals. Clinical data were collected at both the start and end of the 60-day period to examine the A/G ratio and monitor the hematological and biochemical profiles. Results: A significant alteration in the albumin concentration, A/G ratio, and lymphocyte counts was found after remdesivir administration for 60 days. The creatinine-to-Blood Urea Nitrogen ratio was also altered, indicating an improvement in renal metabolism or protein turnover. No significant changes were found in protein and globulin levels, Red Blood Cell indices, platelet counts, electrolytes, and minerals. We also did not find evidence of hepatic injury. Liver enzymes, including Alanine Aminotransferase, Aspartate Aminotransferase, and Gamma-Glutamyl Transferase, the ALT/AST ratio, and total bilirubin did not change, indicating no evidence of remdesivir-induced hepatic injury. Conclusion: The A/G ratio is useful to indicate recovery in FIP-affected cats.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.